157 related articles for article (PubMed ID: 25855505)
21. Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors.
Shao LD; Su J; Ye B; Liu JX; Zuo ZL; Li Y; Wang YY; Xia C; Zhao QS
J Med Chem; 2017 Nov; 60(21):9053-9066. PubMed ID: 29019670
[TBL] [Abstract][Full Text] [Related]
22. Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).
Brasca MG; Mantegani S; Amboldi N; Bindi S; Caronni D; Casale E; Ceccarelli W; Colombo N; De Ponti A; Donati D; Ermoli A; Fachin G; Felder ER; Ferguson RD; Fiorelli C; Guanci M; Isacchi A; Pesenti E; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Fogliatto G
Bioorg Med Chem; 2013 Nov; 21(22):7047-63. PubMed ID: 24100158
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of neolamellarin a derivatives targeting heat shock protein 90.
Jiang L; Yin R; Wang X; Dai J; Li J; Jiang T; Yu R
Eur J Med Chem; 2017 Jul; 135():24-33. PubMed ID: 28426997
[TBL] [Abstract][Full Text] [Related]
24. Assessing the chemical diversity of an hsp90 database.
Audisio D; Messaoudi S; Ijjaali I; Dubus E; Petitet F; Peyrat JF; Brion JD; Alami M
Eur J Med Chem; 2010 May; 45(5):2000-9. PubMed ID: 20170986
[TBL] [Abstract][Full Text] [Related]
25. Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors.
Terracciano S; Chini MG; Piaz FD; Vassallo A; Riccio R; Bruno I; Bifulco G
Eur J Med Chem; 2013 Jul; 65():464-76. PubMed ID: 23770448
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of isoxazolo[5,4-b]pyridines by microwave-assisted multi-component reactions in water.
Tu SJ; Zhang XH; Han ZG; Cao XD; Wu SS; Yan S; Hao WJ; Zhang G; Ma N
J Comb Chem; 2009; 11(3):428-32. PubMed ID: 19364093
[TBL] [Abstract][Full Text] [Related]
27. Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90.
Barta TE; Veal JM; Rice JW; Partridge JM; Fadden RP; Ma W; Jenks M; Geng L; Hanson GJ; Huang KH; Barabasz AF; Foley BE; Otto J; Hall SE
Bioorg Med Chem Lett; 2008 Jun; 18(12):3517-21. PubMed ID: 18511277
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors.
Hanan EJ; Fucini RV; Romanowski MJ; Elling RA; Lew W; Purkey HE; VanderPorten EC; Yang W
Bioorg Med Chem Lett; 2008 Oct; 18(19):5186-9. PubMed ID: 18790636
[TBL] [Abstract][Full Text] [Related]
29. Molecular docking study, synthesis and biological evaluation of Schiff bases as Hsp90 inhibitors.
Dutta Gupta S; Snigdha D; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
Biomed Pharmacother; 2014 Apr; 68(3):369-76. PubMed ID: 24486109
[TBL] [Abstract][Full Text] [Related]
30. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer.
Brough PA; Aherne W; Barril X; Borgognoni J; Boxall K; Cansfield JE; Cheung KM; Collins I; Davies NG; Drysdale MJ; Dymock B; Eccles SA; Finch H; Fink A; Hayes A; Howes R; Hubbard RE; James K; Jordan AM; Lockie A; Martins V; Massey A; Matthews TP; McDonald E; Northfield CJ; Pearl LH; Prodromou C; Ray S; Raynaud FI; Roughley SD; Sharp SY; Surgenor A; Walmsley DL; Webb P; Wood M; Workman P; Wright L
J Med Chem; 2008 Jan; 51(2):196-218. PubMed ID: 18020435
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel aminoquinazolin-7-yl 6,7-dihydro-indol-4-ones as potent, selective inhibitors of heat shock protein 90.
Huang KH; Barta TE; Rice JW; Smith ED; Ommen AJ; Ma W; Veal JM; Fadden RP; Barabasz AF; Foley BE; Hughes PF; Hanson GJ; Markworth CJ; Silinski M; Partridge JM; Steed PM; Hall SE
Bioorg Med Chem Lett; 2012 Apr; 22(7):2550-4. PubMed ID: 22386527
[TBL] [Abstract][Full Text] [Related]
32. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones.
Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD
Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391
[TBL] [Abstract][Full Text] [Related]
33. Targeting the hydrophobic region of Hsp90's ATP binding pocket with novel 1,3,5-triazines.
Lee T; Seo YH
Bioorg Med Chem Lett; 2013 Dec; 23(23):6427-31. PubMed ID: 24125885
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold.
Jia JM; Liu F; Xu XL; Guo XK; Jiang F; Cherfaoui B; Sun HP; You QD
Bioorg Med Chem Lett; 2014 Mar; 24(6):1557-61. PubMed ID: 24582477
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.
Barceló M; Raviña E; Masaguer CF; Domínguez E; Areias FM; Brea J; Loza MI
Bioorg Med Chem Lett; 2007 Sep; 17(17):4873-7. PubMed ID: 17588750
[TBL] [Abstract][Full Text] [Related]
36. Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity.
Kasibhatla SR; Hong K; Biamonte MA; Busch DJ; Karjian PL; Sensintaffar JL; Kamal A; Lough RE; Brekken J; Lundgren K; Grecko R; Timony GA; Ran Y; Mansfield R; Fritz LC; Ulm E; Burrows FJ; Boehm MF
J Med Chem; 2007 Jun; 50(12):2767-78. PubMed ID: 17488003
[TBL] [Abstract][Full Text] [Related]
37. New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.
Rondanin R; Lettini G; Oliva P; Baruchello R; Costantini C; Trapella C; Simoni D; Bernardi T; Sisinni L; Pietrafesa M; Ponterini G; Costi MP; Vignudelli T; Luciani R; Matassa DS; Esposito F; Landriscina M
Bioorg Med Chem Lett; 2018 Jul; 28(13):2289-2293. PubMed ID: 29807796
[TBL] [Abstract][Full Text] [Related]
38. Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold.
Jiang X; Liu H; Song Z; Peng X; Ji Y; Yao Q; Geng M; Ai J; Zhang A
Bioorg Med Chem; 2015 Feb; 23(3):564-78. PubMed ID: 25537530
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
[TBL] [Abstract][Full Text] [Related]
40. Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.
Ermoli A; Bargiotti A; Brasca MG; Ciavolella A; Colombo N; Fachin G; Isacchi A; Menichincheri M; Molinari A; Montagnoli A; Pillan A; Rainoldi S; Sirtori FR; Sola F; Thieffine S; Tibolla M; Valsasina B; Volpi D; Santocanale C; Vanotti E
J Med Chem; 2009 Jul; 52(14):4380-90. PubMed ID: 19555113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
